Amgen is looking to sink more than half a billion dollars into a new science and innovation center in Thousand Oaks. The biotech company has unveiled a plan to invest $600 million into building a research and development facility at its Thousand Oaks headquarters, Bisnow reported. The center is designed to increase collaboration between researchers, engineers and scientists at the biopharmaceutical company, according to L.A. Business First. The new development will demolish and take the place of what Amgen calls “Building 14,” one of the older structures on the campus that is unused, per Bisnow. The new building will be […]
This article originally appeared on The Real Deal. Click here to read the full story.
Powered by WPeMatico